蔡莹

科研工作：一、主持科研课题1. 中国博士后科学基金，2019M663445，HDAC3抑制α-EJ修复通路阻碍HCC发生发展的机制研究，2019.11-2021.11，在研，主持2. 重庆医科大学新型冠状病毒肺炎应急临床研究专项，早期生物学标志物预警重型/危重型新冠肺炎的临床研究，2020.2-2020.5，在研，主持二、科研论文（#共同第一，*通讯作者）1. Ying Cai, Jie Xia, Na Wang, Hengyu Zhou*. Identifcation of prognostic alternative splicing signatures in hepatitis B or/and C viruses related hepatocellular carcinoma. Genomics, 2020 Sep;112(5):3396-3406. (IF: 6.205)2. Hengyu Zhou#, Ying Cai#, Dina Liu, Menghui Li, Yu Sha, Wenlu Zhang, Kai Wang, Jianping Gong, Ni Tang, Ailong Huang*, Jie Xia*. Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21Waf1/Cip1 and p19INK4d upregulation in hepatocellular carcinoma. Cell Proliferation, 2018 Jun;51(3): e12447. (IF: 5.04)  3. An Zhang#, Ying Cai#, Pengfei Wang, Jianning Qu, Zhenchun Luo, Xiaodong Chen, Bin Huang, Yi Liu, Wenqi Huang, Jing Wu, Yuehui Yin*. Diagnosis and prognosis of neutrophil gelatinase-associated lipocalin for acute kidney injury with sepsis: a systematic review and meta-analysis. Critical care, 2016. 20: p. 41. (IF:5.36)4. Ying Cai, Dina Liu, Jing Cui, Yu Sha, Hengyu Zhou, Ni Tang, Na Wang*, Ailong Huang, Jie Xia*. Diagnostic accuracy of red blood cell distribution width to platelet ratio for predicting staging liver fibrosis in chronic liver disease patients: a systematic review and meta-analysis. Medicine (Baltimore), 2019 Apr;98(14): e15096. (IF: 1.87) 5. Ying Cai, Lin Tang. Rare acute kidney injury secondary to hypothyroidism-induced rhabdomyolysis. Yonsei medical journal, 2013. 54(1): p. 172-6. (IF:1.26)工作经历：2008.07-2010.09 重庆医科大学附属第二医院肾内科2013.07-至今重庆医科大学附属第二医院重症医学科2016.08-至今 重庆医科大学感染性疾病分子生物学教育部重点实验室（博士后流动站）

危重症/脓毒症尤其是肾脏、肝脏损伤的早期诊断及全程治疗。